Stockscreener 앱 받기
258.00
2.86%
7.17
시간 외 거래:
258.00
Krystal Biotech Inc 주식(KRYS)의 최신 뉴스
A Look At Krystal Biotech (KRYS) Valuation After Updated Vyjuvek Label And Pipeline Momentum - simplywall.st
Why has Krystal Biotech (KRYS) dropped 11.5% following its most recent earnings announcement? - Bitget
Why Is Krystal Biotech (KRYS) Down 11.5% Since Last Earnings Report? - Yahoo Finance UK
Biotech Investor Adds $3 Million to Krystal Biotech as Revenue Hits $389 Million in 2025 - AOL.com
Quarterly Trades: Is Krystal Biotech Inc impacted by rising ratesMarket Risk Report & Daily Growth Stock Investment Tips - baoquankhu1.vn
Vyjuvek Label Update And KB803 Progress Reshape Krystal Biotech Story - simplywall.st
Is It Too Late To Consider Krystal Biotech (KRYS) After Strong Multi‑Year Share Gains? - Yahoo Finance
Guidance Update: Can Krystal Biotech Inc weather a recession2026 Summary & Expert-Curated Trade Recommendations - baoquankhu1.vn
Updated YJUVEK Label and KB803 Progress Could Be A Game Changer For Krystal Biotech (KRYS) - Yahoo Finance
Whale Trades: Can Krystal Biotech Inc weather a recessionWeekly Stock Recap & Verified Chart Pattern Signals - baoquankhu1.vn
Krystal Biotech slips more than 2% even after Q4 earnings and revenue top estimates - MSN
What to Know About This Obesity Drug Developer That Just Drew a New $7 Million Investment - The Motley Fool
Decheng Capital LLC Sells 33,700 Shares of Krystal Biotech, Inc. $KRYS - MarketBeat
Braidwell LP Cuts Holdings in Krystal Biotech, Inc. $KRYS - MarketBeat
Avoro Capital Advisors LLC Purchases 117,777 Shares of Krystal Biotech, Inc. $KRYS - MarketBeat
Krystal Biotech Stock Surges on Q4 Beat, But Valuation Questions Linger After CEO Share Sale - AD HOC NEWS
Assessing Krystal Biotech (KRYS) Valuation After Q4 2025 Beat And CEO Stock Sale - simplywall.st
First Trust Advisors LP Has $43.85 Million Stake in Krystal Biotech, Inc. $KRYS - MarketBeat
Capital World Investors Cuts Position in Krystal Biotech, Inc. $KRYS - MarketBeat
8,212 Shares in Krystal Biotech, Inc. $KRYS Bought by WINTON GROUP Ltd - MarketBeat
The Bull Case For Krystal Biotech (KRYS) Could Change Following Q4 Beat And CEO Stock Sales - Sahm
Krystal Biotech Insider Sold Shares Worth $6,580,270, According to a Recent SEC Filing - marketscreener.com
(KRYS) Risk Channels and Responsive Allocation - Stock Traders Daily
Krystal Biotech, Inc. $KRYS Position Trimmed by GW&K Investment Management LLC - MarketBeat
Krishnan Krish S, president of Krystal Biotech, sells $6.58 million in KRYS stock - Investing.com
Krystal Biotech (NASDAQ:KRYS) Insider Sells $6,580,250.00 in Stock - MarketBeat
Krystal Biotech director Krishnan sells $6.58 million in shares By Investing.com - Investing.com Nigeria
Krystal Biotech director Krishnan sells $6.58 million in shares - Investing.com
Krystal Biotech (KRYS) R&D president sells 25,000 shares under 10b5-1 plan - Stock Titan
[Form 4] Krystal Biotech, Inc. Insider Trading Activity - Stock Titan
Krystal Biotech Executives Sell Shares Worth Over $13 Million - TradingView
[144] Krystal Biotech, Inc. SEC Filing - Stock Titan
Segall Bryant & Hamill LLC Lowers Stock Position in Krystal Biotech, Inc. $KRYS - MarketBeat
Krystal Biotech Insider Sold Shares Worth $3,252,824, According to a Recent SEC Filing - marketscreener.com
Krystal Biotech at TD Cowen Conference: Strategic Growth and Challenges By Investing.com - Investing.com Canada
Kathryn Romano Sells 750 Shares of Krystal Biotech (NASDAQ:KRYS) Stock - MarketBeat
Daniel Janney Sells 11,803 Shares of Krystal Biotech (NASDAQ:KRYS) Stock - MarketBeat
Daniel Janney sells Krystal Biotech (KRYS) shares worth $3.25 million By Investing.com - Investing.com Canada
Daniel Janney sells Krystal Biotech (KRYS) shares worth $3.25 million - Investing.com
Krystal Biotech (KRYS) CAO sells shares and receives fresh stock awards - Stock Titan
Krystal Biotech (KRYS) R&D chief logs new awards, PSU vesting and tax trades - Stock Titan
Krystal Biotech (NASDAQ: KRYS) CEO reports new equity awards and tax share surrenders - Stock Titan
Alta Bioequities linked to Krystal Biotech (KRYS) director sells 11,803 shares - Stock Titan
Krystal Biotech, Inc. $KRYS Position Increased by William Blair Investment Management LLC - MarketBeat
TD Asset Management Boosts Stake in Krystal Biotech - National Today
TD Asset Management Inc Boosts Position in Krystal Biotech, Inc. $KRYS - MarketBeat
KRYS Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Kathryn Romano sells 12,500 KRYS shares (NASDAQ: KRYS); 750 more vest - Stock Titan
Krystal Biotech, Inc. (KRYS) Stock Analysis: A Promising Genetic Medicine Leader with 13.63% Potential Upside - DirectorsTalk Interviews
Krystal Biotech, Inc. (NASDAQ:KRYS) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Krystal Biotech (KRYS) Is Up 5.6% After Stronger 2025 Profitability And EPS Growth Has The Bull Case Changed? - Sahm
Guggenheim Lifts PT on Krystal Biotech (KRYS) to $284 From $224 - Yahoo Finance
Krystal Biotech director Janney sells shares worth $10.1 million - Investing.com
Krystal Biotech director Janney sells shares worth $10.1 million By Investing.com - Investing.com South Africa
Krystal Biotech (NASDAQ:KRYS) Director Daniel Janney Sells 700 Shares - MarketBeat
Krystal Biotech (NASDAQ:KRYS) Director Daniel Janney Sells 37,895 Shares - MarketBeat
Daniel Janney Sells 7,741 Shares of Krystal Biotech (NASDAQ:KRYS) Stock - MarketBeat
Krystal Biotech Director Janney Daniel Sells Over $16 Million in Company Stock - TradingView
1.20%
0.06%
자본화:
|
볼륨(24시간):